A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea

DSpace Repository

A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea

Author: Schaller, Martin; Kemeny, Lajos; Havlickova, Blanka; Jackson, J. Mark; Ambroziak, Marcin; Lynde, Charles; Gooderham, Melinda; Remenyik, Eva; Del Rosso, James; Weglowska, Jolanta; Chavda, Rajeev; Kerrouche, Nabil; Dirschka, Thomas; Johnson, Sandra
Tübinger Autor(en):
Schaller, Martin
Published in: Journal of The American Academy of Dermatology (2020), Bd. 82, H. 2, S. 336-343
Verlagsangabe: Mosby - Elsevier
Language: English
Full text: http://dx.doi.org/10.1016/j.jaad.2019.05.063
ISSN: 0190-9622
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)